Dependence of proliferative vascular smooth muscle cells on CD98hc (4F2hc, SLC3A2)
about
CD98 increases renal epithelial cell proliferation by activating MAPKs.Loss of T cell CD98 H chain specifically ablates T cell clonal expansion and protects from autoimmunityHomeostatic and innate immune responses: role of the transmembrane glycoprotein CD98.Filter-Dense Multicolor MicroscopyCD98 at the crossroads of adaptive immunity and cancer.Ubiquitylation of CD98 limits cell proliferation and clonal expansionCD98hc (SLC3A2) regulation of skin homeostasis wanes with ageCD98hc (SLC3A2) drives integrin-dependent renal cancer cell behavior.Transport of amino acids in the kidney.In search of underlying mechanisms and potential drugs of melphalan-induced vascular toxicity through retinal endothelial cells using bioinformatics approach.SLC3A2 is upregulated in human osteosarcoma and promotes tumor growth through the PI3K/Akt signaling pathway.Endothelial Cells Require CD98 for Efficient Angiogenesis-Brief Report.Intimal hyperplasia induced by vascular intervention causes lipoprotein retention and accelerated atherosclerosis.Visualization of Synthetic Vascular Smooth Muscle Cells in Atherosclerotic Carotid Rat Arteries by F-18 FDG PET.Conditional deletion of CD98hc inhibits osteoclast development.P2X7 receptor signaling contributes to tissue factor-dependent thrombosis in mice.CD98 regulates vascular smooth muscle cell proliferation in atherosclerosis.The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes.
P2860
Q34328557-335D261F-4D99-4D70-8CAF-5E169610501AQ35091388-1F73107E-57A5-49E3-B359-1A437D3C18ECQ35482842-CE7749EC-783E-49BB-B920-D5C7F70D477DQ35571593-065C22DB-162D-440A-9AB6-8428EEE469ADQ35912427-26AD50CD-FAD1-480C-9408-FA7638E89A82Q36462476-D492D7E0-FD4C-4528-B08D-1845085C198CQ36547682-4BF27A4A-523C-4D4A-BAE4-1C1C1531EC3FQ37427983-F49BD9DB-95F3-47FE-AEA7-EB31151FFEEAQ38201388-530B0312-E1C0-4D31-8188-80CC6FF68421Q38453734-D223049C-0733-4F86-8D81-F56C207928A8Q38710096-35B4D5AD-A174-4690-9581-60847EF723C0Q38736507-38C09DC0-7A0A-45D0-8627-2A35B749C39FQ41160463-768A08EE-2D7A-45BD-8F21-A5B6AB5B34A7Q41203281-8A56EE87-1092-455F-95DB-97AD01C46F28Q41683401-19D65B9D-48DB-4722-9AB9-11EE135C3596Q41813517-618CBC80-2412-469A-A5FC-1CD2EA98766EQ46479215-E9462534-C84C-4171-86CC-4668FEFC0CD7Q52726250-19F2BDFF-4B59-4FC0-A290-6FCBDBC3BE7A
P2860
Dependence of proliferative vascular smooth muscle cells on CD98hc (4F2hc, SLC3A2)
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dependence of proliferative vascular smooth muscle cells on CD98hc (4F2hc, SLC3A2)
@en
Dependence of proliferative vascular smooth muscle cells on CD98hc (4F2hc, SLC3A2).
@nl
type
label
Dependence of proliferative vascular smooth muscle cells on CD98hc (4F2hc, SLC3A2)
@en
Dependence of proliferative vascular smooth muscle cells on CD98hc (4F2hc, SLC3A2).
@nl
prefLabel
Dependence of proliferative vascular smooth muscle cells on CD98hc (4F2hc, SLC3A2)
@en
Dependence of proliferative vascular smooth muscle cells on CD98hc (4F2hc, SLC3A2).
@nl
P2093
P2860
P356
P1476
Dependence of proliferative vascular smooth muscle cells on CD98hc (4F2hc, SLC3A2)
@en
P2093
Mark H Ginsberg
Per Fogelstrand
Ramin Zargham
P2860
P304
P356
10.1084/JEM.20082845
P407
P577
2009-10-19T00:00:00Z